Cargando…
Hepatotoxicity with cholestatic pattern secondary to enoxaparin treatment
OBJECTIVES: Treatment with low-molecular-weight heparins is very common in clinical practice. Exceptionally, some patients develop hepatitis within a few days of starting treatment, and rapid discontinuation of the drug is decisive to avoid chronification. CASE PRESENTATION: These episodes usually p...
Autores principales: | Velasco de Cos, Guillermo, Sánchez-Molina Acosta, Isabel, Iturralde Ros, Marta, Maiztegi Azpitarte, Ainhoa, Moyano Martinez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197442/ https://www.ncbi.nlm.nih.gov/pubmed/37360893 http://dx.doi.org/10.1515/almed-2021-0048 |
Ejemplares similares
-
Hepatotoxicidad colestásica asociada a tratamiento con enoxaparina
por: Velasco de Cos, Guillermo, et al.
Publicado: (2021) -
Voriconazole-Induced Cholestatic Hepatotoxicity in an Immune Competent Patient
por: Mohammed, Yaser, et al.
Publicado: (2022) -
Pathophysiology of cholestatic liver disease and its relevance for in vitro tests of hepatotoxicity
por: Stöber, Regina
Publicado: (2016) -
Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury
por: Alanazi, Najah S., et al.
Publicado: (2021) -
Malignant Hyperthermia Syndrome: A Clinical Case Report
por: Acosta, Isabel Sánchez-Molina, et al.
Publicado: (2021)